Delivery Order SPE2DB20D1050-SPE2DB25FH80H
- Not listed
- The Defense Logistics Agency awarded a $9,081.90 delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Januvia 100 mg, a diabetes medication. This non-set-aside, firm fixed-price contract was executed on July 21, 2025, with an ultimate completion date of July 22, 2025, and represents a child order under AmerisourceBergen's larger contract vehicle. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office...
- The Defense Logistics Agency awarded a $1,117.20 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg, a diabetes management medication. This competitively awarded, firm fixed-price contract was executed on July 25, 2025, with an ultimate completion date of July 28, 2025. The contract carries no set-aside designation and represents a discrete order fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, the company's corporate...
- The Defense Logistics Agency awarded a $7,378.97 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg, a diabetes medication. The contract was competitively awarded without set-aside designation and is scheduled for completion by July 24, 2025. AmerisourceBergen's corporate office, located in Conshohocken, Pennsylvania, serves as the place of performance for this pharmaceutical supply delivery. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $7,401.38 delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Januvia 100 mg, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,091.46 to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside procurement for pharmaceutical supply to federal medical systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order under its...
- The Defense Logistics Agency awarded a $3,683.24 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Januvia 100 mg tablets (90-count) under a firm fixed-price contract. The order, which has an ultimate completion date of July 25, 2025, will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively procured with no set-aside designation and operates as a child contract under a larger vehicle. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Januvia 50 mg tablets (90-count packages) under a firm fixed-price contract with a ceiling value of $1,124.61. This non-set-aside competitive award represents a child delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December...
- The Defense Logistics Agency awarded a delivery order valued at $2,182.92 to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg on July 30, 2025, with a completion date of July 31, 2025. This competitively awarded, firm fixed-price delivery order represents a pharmaceutical supply transaction supporting federal medical procurement needs. The contract carries no set-aside designation and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $2,182.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 90-count tablets of Januvia 100 mg, a diabetes medication. The contract was competitively awarded without set-aside designation and is scheduled for completion by July 29, 2025. This delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00...
- The Defense Logistics Agency awarded a $32,767.22 firm fixed price delivery order to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg, with an ultimate completion date of July 28, 2025. This non-set-aside competitive award was issued on July 25, 2025, with performance at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills this order as a child delivery order...
- SPE2DB20D1050Indefinite Delivery Contract
- SPE2DB20D1050-SPE2DB25FH80HDelivery Order
The Defense Logistics Agency awarded a $1,942.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for 90 tablets of Januvia 100 mg, a diabetes management medication. This non-set-aside contract is a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. AmerisourceBergen Drug Corp, a major pharmaceutical distributor serving federal medical procurement needs, was competitively selected for this delivery order through the DLA's Medical Supply Chain. The company supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems, the Defense Health Agency, U.S. Coast Guard, and other government healthcare organizations. This transaction is representative of the company's portfolio of routine pharmaceutical deliveries executed under its comprehensive global pharmaceutical support vehicle, which enables flexible fulfillment of medical supply requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 7/28/25 |